FDA fast-tracks Pfizer and Lilly’s chronic pain drug
June 15, 2017Research and Development, Sales and Marketing Eli Lilly, FDA, Pfizer
Pfizer and Eli Lilly are celebrating the FDA’s decision to grant fast-track designation to their joint venture tanezumab in the …
EMA lags behind FDA on continuous manufacturing regulation
June 15, 2017Manufacturing and Production EMA, FDA, continuous manufacturing
Continuous manufacturing is increasingly an area of fixation within the pharma industry for the benefits it can bring to the …
Novartis’ Cosentyx shines in ankylosing spondylitis and psoriatic arthritis
June 15, 2017Research and Development Cosentyx, Novartis
Novartis has released new data on the efficacy of its drug Cosentyx (secukinumab) in the treatment of life-long inflammatory diseases …
LifeArc rebrands and sets up £500m research fund
June 15, 2017Medical Communications, Research and Development, Sales and Marketing LifeArc, MRC Technology, keytruda
The UK medical research charity formerly known as MRC Technology has rebranded to be known as LifeArc. At the same …
Trump appoints new Director of the National Cancer Institute
June 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing National Cancer Institute, appointment
Dr Norman Sharpless has been named as Director of the National Cancer Institute (NCI), part of the National Institutes of …
PrimeVigilance is committed to minimising the impact of UK’s Withdrawal from the EU
June 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, primevigilance
Guildford, UK 14th June, 2017
Alexion secures ex-Biogen Chief Financial Officer
June 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, Biogen, appointment
Alexion Pharmaceuticals has announced that it has snatched up Biogen’s long-serving Chief Financial Officer Paul Clancy and will instate him …
Bhutan and Maldives successfully eliminate measles
June 14, 2017Medical Communications, Research and Development WHO, immunisation, measles, rubella
The WHO has announced that Bhutan and Maldives have become the first South-East Asia region countries to successfully eliminate measles. …
Celltrion biosimilar proves effectiveness in lymphoma and rheumatoid arthritis
June 14, 2017Research and Development Cellltrion, Truxima, biosimilar, lymphoma, rheumatoid arthritis, rutiximab
Celltrion Healthcare has revealed new data which validates its biosimilar Truxima (CT-P10) as non-inferior to its reference product rituximab in …
Reversal of type 1 diabetes possible through century-old vaccine
June 14, 2017Research and Development BCG, Type 1 diabetes, Vaccine, diabetes
The American Diabetes Association 77th Scientific Sessions closed yesterday and one of the most interesting pieces of research to emerge …
FDA to review effectiveness of abuse deterrent opioid drugs
June 14, 2017Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid, opioid crisis
FDA Commissioner Scott Gottlieb continues his fightback against the US opioid crisis after requesting an unprecedented recall of Endo Pharmaceuticals’ …
Genetic test reveals at-risk men for testicular cancer
June 14, 2017Research and Development ICR, Movember Foundation, testicular cancer
Research emerging from the Institute of Cancer Research has revealed the men most statistically at-risk of developing testicular cancer. The …
BMS vet joins Kleo Therapeutics as CEO
June 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Kleo Pharmaceutical
Kleo Pharmaceutical has moved to appoint industry veteran Doug Manion to the position of CEO. Kleo are a biotech company …
MSD forced to pause enrolment after Keytruda deaths
June 13, 2017Manufacturing and Production, Research and Development
MSD has been hit by a major surprise after an independent monitoring committee raised a warning after an imbalance in …
Prescription costs vary wildly between high-income countries
June 13, 2017Manufacturing and Production, Sales and Marketing medicine, prescription, prescription cost
A study originating out of Canada has laid bare the difference in cost of primary care prescription drugs between different …
Sun Pharma rises again with FDA cholesterol drug approval
June 13, 2017Manufacturing and Production Sun Pharma
Sun Pharma has had a rough time of late, the FDA has become more aggressive in its overseeing of manufacturing …
FDA approves BioMarin’s Irish facility
June 13, 2017Manufacturing and Production BioMarin, Ireland, cork, vimizin
The FDA has approved BioMarin’s bulk biologic manufacturing plant, based in Cork, Ireland. The facility will manufacture an ingredient of …
SMC reverses decision on Opdivo for kidney cancer
June 12, 2017Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, SMC, opdivo
The Scottish Medicines Consortium (SMC) has performed a U-turn on its decision regarding Opdivo (nivolumab), and will now allow patients …
European Medicines Agency: Staying consistent in a turbulent time
June 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, European Medicines Agency, brexit
With Brexit looming, the future of the EMA headquarters in London has been cast in doubt. Pharmafocus spoke to Marie-Agnes …
FlyPharma Conference 2017 – “Collaboration is the key”
June 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FlyPharma conference, PHARMA SUPPLY CHAIN, flypharma, supply chain
As the conference came to a conclusion, audience members were invited to offer their thoughts on what the overall message …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
